Meta-analysis of photobiomodulation for the treatment of androgenetic alopecia

References

• Crabtree JS, Kilbourne EJ, Peano BJ, et al. A mouse model of androgenetic alopecia. Endocrinology. 2010;151(5):2373–2380.
   PubMed Web of Science ®Google Scholar
• Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol. 1993;29(4):568–575.
   PubMed Web of Science ®Google Scholar
• Alfonso M, Richter-Appelt H, Tosti A, et al. The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin. 2005;21(11):1829–1836.
   PubMed Web of Science ®Google Scholar
• Budd D, Himmelberger D, Rhodes T, et al. The effects of hair loss in European men: a survey in four countries. Eur J Dermatol. 2000;10(2):122–127.
   PubMed Web of Science ®Google Scholar
• Mella JM, Perret MC, Manzotti M, et al. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141–1150.
   PubMed Web of Science ®Google Scholar
• Lanzafame RJ, Blanche RR, Bodian AB, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers Surg Med. 2013;45(8):487–495.
   PubMed Web of Science ®Google Scholar
• Lanzafame RJ, Blanche RR, Chiacchierini RP, et al. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers Surg Med. 2014;46(8):601–607.
   PubMed Web of Science ®Google Scholar
• Esmat SM, Hegazy RA, Gawdat HI, et al. Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: a randomized controlled study. Lasers Surg Med. 2017;49(9):835–843.
   PubMed Web of Science ®Google Scholar
• Mai-Yi Fan S, Cheng Y-P, Lee M-Y, et al. Efficacy and safety of a low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, self-comparison, sham device-controlled trial. Dermatol Surg. 2018;44(11):1411–1420.
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Srisuwanwattana P, Chalermroj N, et al. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2018;32(12):2257–2263.
   PubMed Web of Science ®Google Scholar
• Friedman S, Schnoor P. Novel approach to treating androgenetic alopecia in females with photobiomodulation (low-level laser therapy). Dermatol Surg. 2017;43(6):856–867.
   PubMed Web of Science ®Google Scholar
• Barikbin B, Khodamrdi Z, Kholoosi L, et al. Comparison of the effects of 665 nm low level diode Laser Hat versus and a combination of 665 nm and 808 nm low level diode Laser Scanner of hair growth in androgenic alopecia. J Cosmet Laser Ther. 2017. DOI:https://doi.org/10.1080/14764172.2017.1326609. [Epub ahead of print]
   Google Scholar
• Avram MR, Rogers NE. The use of low-level light for hair growth: part I. J Cosmet Laser Ther. 2009;11(2):110–117.
   PubMed Web of Science ®Google Scholar
• Leavitt M, Charles G, Heyman E, et al. HairMax LaserComb® laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283–292.
   PubMed Web of Science ®Google Scholar
• Munck A, Gavazzoni MF, Trüeb RM. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. Int J Trichology. 2014;6(2):45–49.
   PubMedGoogle Scholar
• Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115–127.
   PubMed Web of Science ®Google Scholar
• Faghihi G, Mozafarpoor S, Asilian A, et al. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2018;84(5):547–553.
   PubMed Web of Science ®Google Scholar
• Bertin ACJ, Vilarinho A, Junqueira ALA. Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss. J Cosmet Laser Ther. 2018;20(7-8):391–394.
   PubMed Web of Science ®Google Scholar
• Cho SB, Goo BL, Zheng Z, et al. Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study. Lasers Med Sci. 2018;33(4):851–859.
   PubMed Web of Science ®Google Scholar
• Panchaprateep R, Pisitkun T, Kalpongnukul N. Quantitative proteomic analysis of dermal papilla from male androgenetic alopecia comparing before and after treatment with low-level laser therapy. Lasers Surg Med. 2019;51(7):600.
   PubMed Web of Science ®Google Scholar
• Tabaie SM, Ardestani HB, Azizjalali MH. The effect of one session low level laser therapy of extracted follicular units on the outcome of hair transplantation. J Lasers Med Sci. 2016;7(1):26–29.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Kim H, Choi JW, Kim JY, et al. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013;39(8):1177–1183.
   PubMed Web of Science ®Google Scholar
• Liu K-H, Liu D, Chen Y-T, et al. Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials. Lasers Med Sci. 2019;34(6):1063–1069.
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Chalermroj N, Khunkhet S. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci. 2018;34:1107.
   PubMed Web of Science ®Google Scholar
• Avci P, Gupta GK, Clark J, et al. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med. 2014;46(2):144–151.
   PubMed Web of Science ®Google Scholar
• Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol. 1993;28(5):755–763.
   PubMed Web of Science ®Google Scholar
• Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol. 1992;127(3):239–246.
   PubMed Web of Science ®Google Scholar
• Novák Z, Bónis B, Baltás E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J. Photochem Photobiol B. 2002;67(1):32–38.
   PubMed Web of Science ®Google Scholar
• Huang Y-Y, Chen AC-H, Carroll JD, et al. Biphasic dose response in low level light therapy. Dose-Response. 2009;7(4):358–383.
   PubMed Web of Science ®Google Scholar
• Karu TI, Afanas’eva NI. [Cytochrome c oxidase as the primary photoacceptor upon laser exposure of cultured cells to visible and near IR-range light]. Dokl Akad Nauk Ross Akad Nauk. 1995;342(5):693–695.
   PubMedGoogle Scholar
• Karu TI, Kolyakov SF. Exact action spectra for cellular responses relevant to phototherapy. Photomed Laser Surg. 2005;23(4):355–361.
   PubMed Web of Science ®Google Scholar